Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Oslo University Hospital
Femme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
Phase I/II trial of vaccine therapy in patients with recurrent ovarian cancer
Safety and toxicity of vaccination with DCs transfected with amplified ovarian cancer stem cell mRNA, h-TERT mRNA and survivin mRNA in patients with relapsed and platinum resistant ovarian cancer.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
MRI contrast agent in the spinal canal of adults with cerebrospinal fluid circulation disorders
To determine distribution of contrast agent as assessed by repeated cranial MRI.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Homme Max 99 ans
Oslo University Hospital healt Trust
MAJ Il y a 4 ans
New treatment for Klamydia infection. Ny behandling for Klamydiainfeksjon
The objective of the study is to prove the concept of treating genital Chlamydia trachomatis infection with mecillinam po..
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme Max 99 ans
Oslo University Hospital, Division of Emergencies and Critical Care
MAJ Il y a 4 ans
A study of the effects of oxytocin and carbetocin on the heart
Cardiac biomarkers may increase after injection of oxytocin. Carbetocin, a new synthetic oxytocin receptor agonist, may have similar effects. This study compares the two drugs in clinical use for trea...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
Phase I/II trial of vaccine therapy in curative resected prostate cancer patients using autologous dendritic cells loaded with mRNA from primary prostate cancer tissue, hTERT and surviving
Safety and toxicity of vaccination with DCs transfected with h-TERT mRNA, survivin mRNA and autologous tumor cell mRNA andlymphnodepletion treatment in patients with prostatic cancer. Time to treatme...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Précédent
1
2
3
4